We studied the association between coronary artery disease (CAD) and polymorphisms of the ABCA1, ACE, AGT, eNOS and EFNB3 genes in 85 Russian patients with angiography-proven CAD and 100 of their siblings. No gene analyzed had a z-score value of more than 2.47 for CAD or for its main clinical presentations due to sibling transmission/ disequilibrium test (S-TDT). However, the DD genotype of ACE is significantly more prevalent in siblings with CAD [p = 0.025, relative risk (RR) 2.8], angina (p = 0.028, RR = 3.3) and myocardial infarction (MI) (p = 0.018, RR = 5.5). An increased risk of CAD, and its main manifestations, was associated with the R1587 allele of the ABCA1 gene: the RR for developing CAD was 4.88, for MI 6.18, and for angina 3.69 for siblings who were carriers of the R1587R and R1587K genotypes. Index of stenosis was significantly higher in probands with the K219K and R219K genotypes (p = 0.001). The combination of genotype K219K with R219K was more frequent among siblings with CAD (p = 0.044, RR = 2.38), arterial hypertension (p = 0.023, RR = 2.87) and angina (p = 0.027, RR = 3.3). Thus, none 
INTRODUCTION
Atherosclerosis, the primary cause of coronary artery disease (CAD), is the leading cause of human morbidity and mortality in industrialized and developing countries [1] . The etiology of CAD is multifactorial, with many genetic and environmental determinants, including cigarette smoking, alcohol consumption, diabetes mellitus, obesity, aging, elevated blood pressure, elevated serum levels of low-density lipoprotein-cholesterol (LDL-C) and low serum levels of high-density lipoprotein-cholesterol (HDL-C).
Several candidate genes could determine individual susceptibility of blood vessels in the myocardium to develop atherosclerosis and CAD; a number of gene poly morphisms associated with an elevated risk of myocardial infarction (MI) have now been identified [2] [3] [4] . Numerous studies have revealed associations between elevated blood LINKAGE ANALYSIS IN PATIENTS WITH CAD pressure and CAD, and many candidate genes, particularly members of the renin-angiotensin system, have been investigated [5] [6] [7] [8] [9] [10] . Both linkage and association studies have provided strong evidence for the role of the angiotensino gen (AGT) gene in hypertension in different populations [11] [12] [13] . The angiotensin-converting enzyme (ACE) gene plays a key role in the renin-angiotensin system and is associated with CAD [14] . The insertion/deletion (I/D) polymorphisms in the 16th intron of the ACE gene were identified in 1990 [15] . Analysis of ACE levels in the blood plasma of individuals of various populations demonstrated that homozygotes for the D allele had the highest ACE activity [14, 16] and were at higher risk of developing MI and CAD [14, 17] .
The most significant risk factors for CAD are related to lipoprotein metabolism. Plasma lipoprotein disturbances are among the most common biochemical abnormalities observed in patients with CAD [18]. The HDL-C level is strongly inversely correlated with developing CAD [19, 20] . This antiatherogenic property of HDL is mainly due to its role in reverse cholesterol transport. The ATP binding cassette transporter 1 (ABCA1) protein has been identified as a mediator of cholesterol efflux [21, 22] . ABCA1 stimulates cholesterol and phospholipid efflux to apolipo protein A1 (the main component of HDL) and may act as a cholesterol/phospholipid flippase at the plasma membrane level (for reviews see [23, 24] ).
Several common polymorphisms have been reported in the coding and promoter regions of the ABCA1 gene [25, 26] . Some are associated with altered plasma lipid levels and with the development of CAD. For example, the R219K polymorphism is associated with progression of atherosclerosis and with elevated triglyceride (TG) and HDL-C levels in familial hypercholesterolemia patients from Spain [27] . Other single-nucleotide polymorphisms in the coding region had milder effects on plasma lipids and atherosclerosis [25] .
Nitric oxide (NO) is a cell signaling molecule that plays an important role in physiological processes such as regulation of the vascular system, neurotransmission and various homeostatic events. It may exhibit either athero genic or atheroprotective effects, depending on its source. Thus, the vasodilator function of NO produced by endothelial NO synthase (eNOS) is protective. Deletion of the eNOS gene in a background of apoE deficiency results in hypertension and increased atherosclerosis [28] . Several polymorphisms have been found in the eNOS gene [29] , and some have been associated with increased cardiovascular risk [30, 31] .
Ephrins (EFNs) are cell-surface ligands of ephedrine receptor tyrosine kinases. They are classified into A and B subfamilies; EFNBs comprise three transmembrane proteins (EFNB1-3), which are capable of reverse transmission of signals into cells. Such functions are well demonstrated in the central nervous system, during angiogenesis and in intestinal development and remodeling [32] [33] [34] [35] [36] . EFNB3 plays a role in cardiovascular development [34] .
In this study, we analyzed polymorphisms in the genes for ABCA1, ACE, AGT, eNOS and EFNB3 in 85 Russian patients with angiography-proven CAD and 100 of their siblings.
MATERIALS AND METHODS
Study Subjects. We recruited 85 Russian subjects among patients who attended the All-Russian Center for Preventive Medicine, Moscow, Russia, for CAD treatment. Inclusion required at least 50% stenosis in one or more major coronary arteries. We also analyzed 100 full siblings of these patients. Informed consent was provided by the participants before the investigations and the study was approved by the local Ethics Committee. Some clinical and biochemical characteristics of patients and their siblings are presented in Table 1 .
Assessment of Coronary Artery Disease. Computer-assisted quantitative coronary angiography was assessed using a vessel score and a stenosis score. The former was the number of coronary vessels with significant stenosis (60% or greater reduction in lumen diameter) and ranged from 0 to 3. The latter was calculated according to a modified Gensini method [37] , in which the most severe stenosis in each of eight segments was assigned to grade 1 if there was 1-49% reduction in lumen diameter, grade 2 for 50-74%, grade 3 for 75-99% and grade 4 for total occlusion. The scores in all of the eight segments were added to give a total out of a theoretical maximum of 32.
Plasma Lipid and Lipoprotein Measurements. Blood samples were collected from subjects after a minimal 10-hour fast. Aliquots of plasma were frozen at -20°C before measurement of lipid, lipoprotein and apo lipoprotein levels. Total cholesterol, HDL-C and TG levels were measured using enzymatic assay kits from Roche Diagnostics (Basel, Switzerland). HDL-C was measured as the level of cholesterol that remained in the supernatant after precipitation of the apoB-containing lipoproteins with dextran sulfatemagnesium. LDL-C was calculated using the equation of Friedewald et al. [38] . Genotyping. DNA was extracted by standard methods using proteinase K/phenol/chloroform treatment [39] . The polymorphism for each gene was determined by polymerase chain reaction (PCR) amplification and restriction enzyme cleavage. Genomic DNA (0.1 µg) was amplified in 20 µL of reaction mixture containing 5 pM of each primer, 1 mM of each dNTP, 2 µL of 10 × reaction buffer [500 mM Tris-HCl, pH 8.8, 150 mM (NH 4 ) 2 SO 4 , 50 mM MgCl 2 , 2 mg/mL BSA, 0.1% Tween and 0.1% gelatin] and 0.5 units Taq DNA polymerase. After the DNA had been denatured for 5 min. at 95°C, the reaction mixture was subjected to 30 cycles of denaturation for 1 min. at 95°C, annealing for 1 min. and extension for 1 min. at 72°C. The polymorphism was detected by digestion of the PCR-amplified fragment with particular restriction enzymes, separation on 6% polyacrylamide gels and visualization of fragments with ethidium bromide staining. The forward and reverse primers, restriction enzymes and fragment size for each locus are shown in Table 2 .
Statistical Analysis. Statistical analysis was performed using the software STATISTICA, version 6.0. The linkage between CAD and each of the genes Table 1 . Clinical and biochemical data of the proband and sibling groups under study. 
, where A and B are the numbers of patients with and without genetic markers, respectively, and C and D are the numbers of healthy subjects with and without genetic markers, respectively. Confidence intervals were calculated as:
Correlations of physical and biochemical variables with different genotypes were determined by γ correlation analysis after correction of the primary data for sex, body mass index (BMI) and age. Comparisons of variables between groups with different single-locus genotypes were determined by contingency table analysis for categorical measures and by independent Student's t tests for continuous traits. Data without a normal distribution were log transformed before analysis. Comparisons of means values in groups with different single-locus genotypes were performed using the Newman-Keuls test.
eNOS4a/4b and the C/A polymorphism of EFNB3. We first determined the possibility of linkage between CAD and each of the genes studied using the S-TDT (Table 3) . No gene had a z-score greater than 2.47 for CAD or for its main manifestations of acute MI and angina. Thus, none of the five genes can be considered as the main gene associated with the disease, but these genes can affect disease development. Therefore, non parametric γ correlation analysis was performed to assess the influence of the gene polymorphisms on the clinical and biochemical characteristics in the proband and sibling groups.
ACE Gene Insertion/Deletion Polymorphism. Table 4 shows the γ correlation between the ACE I/D polymorphism and clinical and biochemical characters in CAD patients and their siblings. In the CAD group, this polymorphism correlated significantly with the level of HDL-C. In the sibling group, there were significant correlations with CAD, acute MI, and the severity of angina, valvular atherosclerosis and left ventricular hypertrophy. Further analyses on the CAD group using the Newman-Keuls test did not reveal significant levels of correlation between the mean values of HDL-cholesterol in probands with different ACE genotypes. Table 5 shows the distribution of ACE genotypes for siblings with or without CAD, angina and MI. The DD genotype was significantly more prevalent among the siblings who had CAD than in the healthy siblings (p = 0.025). The RR for developing CAD was 2.8 for siblings with the DD genotype (95% CI 1.12-7.04). The DD genotype frequency was also higher in siblings with angina (p = 0.028), for whom the RR was 3.3 (95% CI 1.14-9.59). The most significant results were observed for siblings with MI, where the DD genotype had a RR of 5.5 (95% CI 1.37-22.04), p = 0.018.
In subjects with valvular atherosclerosis and left ventricular hypertrophy, χ2 testing did not reveal significant associations with any ACE genotype. We conclude that the DD ACE genotype in the Russian R219K and R1587K Polymorphisms of ABCA1. We tested for two common coding single-nucleotide polymor phisms of the ABCA1 gene, i.e., R219K and R1587K. Table 6 shows the γ correlations between the R219K polymorphism and clinical and biochemical data in patients and siblings. In the patient group, this polymorphism correlates with angina, LDL-C level, and especially with parameters that affect the sclerosis of coronary arteries. In the sibling group, there was a correlation with the incidence of CAD by itself, as well as with angina, hypertension and very low-density lipoprotein-cholesterol (VLDL-C) and TG levels.
For further analysis of correlations, we combined the RK heterozygotes and KK homozygotes into one genotype group because of the scarcity of individuals with the latter genotype. Figure 1 shows that the index of stenosis was significantly higher in subjects with the RK or KK genotypes than in those with only the RR genotype. Patients with the KK and RK genotypes more frequently showed in two or three vessel lesions (Table 7) . Similar studies were carried out in the sibling group. Table 8 shows the genotype distribution in siblings with and without CAD, angina and arterial hypertension. The combination of genotype KK with RK was frequent among siblings with CAD; the RR being 2.38 (95% CI 1.02-5.80), p = 0.044. Results were similar for arterial hypertension (RR = 2.87; 95% CI 1.26-6.56), (p = 0.023) and angina (p = 0.027). The RR value for siblings with the KK and RK genotypes was 3.3 (95% CI 1.08-10.23).
Results for the polymorphic R1587K site in this gene using non parametric γ correlation analysis are shown in Table 6 . For probands with CAD, this polymorphism did not influence the main CAD clinical presentations (such as MI and the severity of angina) or the degree of coronary artery atherosclerotic lesions (vessel index, stenosis index or coronary artery occlusions). There were no apparent effects of this polymorphism on the plasma lipid spectrum. However, among the sibling group, there were very significant correlations between the R1587K polymorphism and CAD, MI and angina. Thus, the increased risk of CAD and its main manifestations is associated with RR genotypes. The RR value for developing CAD among subjects with RR genotype was 4.88 (95% CI 4.14-7.62), for MI it was 6.18 (95% CI 2.26-10.1) and for angina, 3.69 (95% CI 2.00-5.18) ( Table 9) .
Thus, among this Russian population, the ABCA1 gene R1587K polymorphism was associated with a Table 7 . The R219K ABCA1 gene polymorphism and artery measurements by coronary angiography. Vessel index is the number of vessels with stenosis of more than 50%: 1 = one vessel; 2 = two vessels; 3 = three vessels. Table 8 . Genotype distribution at the R219K polymorphism of the ABCA1 gen in the sibling group either with or without coronary artery disease, angina and arterial hypertension. Analysis of eNOS4a/4b, the M235T Polymorphism of AGT and the C/A (BamHI) Polymorphism of EFNB3. Table 10 shows the γ correlation test for the AGT polymorphism of M235T, and for eNOS minisatellite 4a/4b and EFNB3 BamHI polymorphism. For each polymorphism, there appeared to be at least one significant correlation with a given disease characteristic. However, further analyses by χ2 and Newman-Keuls tests did not reveal any significant correlations of clinical parameters with any of the corresponding genotypes.
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the ACE gene correlated significantly with CAD and its clinical presentations (angina and MI) in the sibling group but not in the patient group. Among siblings with the DD genotype, the RR of developing CAD was 2.8 (95% CI 1.12-7.04), of angina 3.3 (95% CI 1.14-9.59) and of MI 5.5 (95% CI 1.37-22.04).
Analysis of the blood plasma ACE level of other populations and in individuals with different genotypes demonstrated that the homozygotes for the D allele had the highest levels and also an increased risk of developing CAD and MI [14, 16, 17] . However, the results are controversial and do not provide a clear understanding of the role of this polymorphism in the genesis of these diseases [41, 42] .
We found that the R219K polymorphism of the ABCA1 gene correlated with the incidence of angina, with LDL-C levels and especially with parameters affecting sclerosis of the coronary arteries in the patient group. The K219K and R219K genotypes were associated with more severe atherosclerotic lesions of the coronary arteries than the R219R genotype. In addition, allele 219K and its related genotypes were associated with higher risks for CAD by itself, and for angina and arterial hypertension in the sibling group.
Many studies are available with analyses of different polymorphism of ABCA1 gene. Clee et al. [25] 
DISCUSSION
We analyzed the polymorphisms of several genes in patients with angiography-proven CAD and their siblings in a Russian population. The S-TDT evaluation found no linkage between CAD and each of these genes; the z-score was below 2.47, so none of these genes can be considered as the main cause of the disease. However, two genes, ACE and ABCA1, showed association with the risk of developing CAD and its main clinical presentations for those subjects who had siblings affected by CAD. The I/D polymorphism of Here, in our Russian population, carriers of allele 219K and its related genotypes, were associated with higher risks for CAD by itself and also for angina and arterial hypertension. These contrary data suggest that the R219K polymorphism is probably a marker which is associated with other functionally significant polymorphisms that influence CAD. There were very significant associations between the R1587K genotype and the risk of developing CAD, MI and angina among the siblings of patients with CAD. Thus, the increased risk of CAD and its main manifestations is associated with the R1587 allele. The RR for developing CAD in the carriers of genotypes R1587R and R1587K was 4.88 (95% CI 4.14-7.62). Evidently, the rare allele 1587K is protective and reduces the risk of CAD. Such a correlation has not been described previously. Clee et al. [25] did not find any correlation of this polymorphism with CAD or with the characteristics of athero sclerotic vessel lesions (such as effective arterial diameter or minimum arterial diameter) for a Dutch population. In addition, there was no association of the R1587K polymorphism with MI among populations in Northern Ireland or Scotland [4] . Clearly, there are ethnic differences in the influence of the R1587K polymorphism on the risk of developing CAD.
The association of the R1587K polymorphism with CAD in our sample was not connected to its effect on plasma lipid levels. An association between plasma lipid level and the R1587K ABCA1 gene variants was described by Clee et al. [25] . In a Danish population, low HDL-C levels were found in patients with K1587K and R1587K genotypes (which lowers the risk of developing CAD in our Russian population). Only an association of the R1587K polymorphism with apoA1 level was found in samples from Glasgow and Belfast [4] . Therefore, the association between the R1587K polymorphism and plas ma lipid spectrum may be population-specific. This suggests that the R1587K polymorphism may be an independent genetic marker of CAD risk and MI for Russians with a family history of cardiovascular diseases.
It is especially interesting that this R1587K polymorphism was not in significant linkage disequilibrium with other ABCA1 gene polymorphic sites, in particular with the R219K polymorphic site [25] . These two polymor phisms are localized in different regions of the ABCA1 gene and possibly determine different functions of ABCA1 protein.
Further research conducted in a large group of patients should help clarify the importance of this association in different populations.
Our analyses did not reveal any significant correlations between the M235T polymorphism of the AGT gene and higher risk of CAD development. Moreover, Rodrigues-Perez et al. [46] detected that the 235T allele was significantly more frequent in patients with CAD than in controls. Buraczynska et al. [47] revealed that the T235T genotype of the AGT gene M235T polymorphism was associated with an increased risk of CAD and MI. At the same time, Sekuri et al. [48] demonstrated that increased premature CAD risk is associated with higher frequencies of the AGT M235M genotype. No evidence was found for an association of the eNOS minisatellite 4a/4b polymorphism with CAD in our research and in investigations by Gardemann et al. [49] . However, another polymorphism of this gene was found to be associated with CAD and MI [49, 50] . Schneider et al. [51] supposed that the observed association between the Glu258Asp polymorphism of the eNOS gene and various cardiovascular disorders could be explained on the basis of altered endothelium-dependent vasodilatation. However, they did not reveal a major effect of the Glu258Asp polymorphism of the eNOS gene on endothelium-dependent vasodila tation.
These contrary data suggest that the mechanism of CAD development still remains completely unknown. Future analyses will promote our deeper
